Follow-up of a cohort of patients who received umbilical cord blood transplantation with malignant and non-malignant haematological diseases FRESH-PEF60097-en Vanderson ROCHA Follow-up of a cohort of patients who received umbilical cord blood transplantation with malignant and non-malignant haematological diseases EUROCORD FRESH-PEF60097-en 60097 FRESH-PEF60097 Vanderson ROCHA UNIVERSITE PARIS CITE Epidemiology France Portal (PEF) AGENCE DE LA BIOMEDECINE ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (AP-HP) null Vanderson;ROCHA engraftment reaction graft against the host acute chronic Health episodes relapse mortality Cardiology and vascular medicine Hematology Malignant haematopoietic neoplasms without further specification Healthcare system determinants: Use of care Healthcare system determinants General objective: To collect clinical data for new transplant patients and updating cohort follow-up for analysis of prognostic factors from transplantation results in Europe and globally with one or two units of cord blood from umbilical cord blood banks located in France, Europe or internationally. Secondary Objective: To improve data recovery through the creation of an electronic system for collecting data online for cord blood banks in order to facilitate the flow of information from these banks and allow the retrieval of non-analysed to date. To restructure the current information system, notably thanks to the development of new technologies for database management and the application of international standards. To develop a network of electronic communication with other existing databases with PROMISE (EBMT register for bone marrow transplants), Netcord (bank network), the NMDP and CIBMTR in the USA. null United Kingdom Sweden Norway Germany Italy Spain France Belgium Congo Iceland Denmark Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) All patients who received one or two units of umbilical cord blood in Europe or international patients who received one or two units of cord blood from European banks Participant-reported health data Health event/morbidity Health event/mortality Other Through organizations (health services or institutions schools businesses etc.) [1000-10000[ individuals Interview with the participant (including clinical) Observational Study Observational Study Cohort study 4724 Unknown Restricted access Data may be used by academic teams . To be defined if data may be used by industrial teams. Access determined by the Eurocord Scientific Council, The French Stem Cell Society (sfgm-tc) and EBMT.Contractual access with Biotech and pharmaceutical industry in discussion, but not currently active Access on specific project only